Exclusives - Spark Newswire

2 minute read

EXCLUSIVE: Will Alphabet, Amazon, Apple Or Tesla See Biggest Increase In 2023? 44% Of Benzinga Followers Picked This Stock

Today, 2:42 AM

The stock market had a rough year in 2022 with many top indexes seeing decade lows. Many large-cap technology stocks were among the biggest losers of the year. To kick off 2023, Benzinga polled its followers to see which popular stock might have the best 2023.

AAPL

2 minute read

‘You Can’t Ignore Us. Here We Are’ — Brock Pierce On Blockchain Hub Davos 2023

By Justin Roberti

Today, 2:42 AM

While the World Economic Forum (WEF) annual meeting begins in mid-January in Switzerland, the Web3 community will be represented in their parallel conference — Blockchain Hub Davos 2023.

$USDT

4 minute read

Exclusive: ‘People Want To Hear About Revenue Now, Not Bulls***’ — Why Citron Research Is Short Luminar Technologies Stock

By Chris Katje

Today, 2:42 AM

One of the themes of the last two years has been a growing number of lidar technology companies going public — many chose the SPAC route. A hedge fund is now taking on one of those companies and shared with Benzinga exactly why.

INVZ

2 minute read

EXCLUSIVE: What Are The Issues Americans Consider Most Important Ahead Of 2024 Presidential Election

By Chris Katje

Today, 2:42 AM

With the calendar turning over to 2023, the U.S. is less than two years away from the 2024 election that will decide who the next president will be. Here’s a look at what some of the most important global issues are for voters.

SPY

2 minute read

EXCLUSIVE: “I Am Coming For You,” Kevin O’Leary Declares War On Hackers After Twitter Account Hacked

By Justin Roberti

Today, 2:42 AM

“Shark Tank” co-host and investor Kevin O’Leary’s Twitter account @kevinolearytv was hacked earlier today.

$FTT

2 minute read

EXCLUSIVE: The Benzinga Moneymaker Series, 5 Emerging Stocks For Investors To Watch

By Chris Katje

Today, 2:42 AM

Investors are on the hunt for undervalued, underfollowed and emerging stocks to spot opportunities. The rise of social media and retail traders gave way to countless methods to uncover new information. For some, this is overwhelming.

GRRR

3 minute read

High Tide CEO: 2023 Expectations, Why US Strategy Does NOT Hinge On Cannabis Legalization

By Anthony Noto

Today, 2:42 AM

Throughout 2022, several more states — Missouri,

HITI

1 minute read

EXCLUSIVE: Alzamend Neuro Partners With Stem Cell Institute For Immunotherapy Vaccine Trial For Dementia

By Vandana Singh

Today, 2:42 AM

Alzamend Neuro Inc (NASDAQ: ALZN) has partnered with the Miller School of Medicine, Interdisciplinary Stem Cell Institute at the University of Miami for its Phase 1/2A trial of ALZN002.

ALZN